28
nanotimes
Companies Facts
• Total revenues up 18.5% year-over-year to $25.4 Million;
• III-V revenue increases 110% on momentum of mobile connectivity and smart phone demand;
• Kopin exits first quarter with $119 million in cash and marketable securities and no debt;
• Company Affirms 2010 Guidance for Revenue of $120-$130 Million.
Total sales increased 18.5% to $25.4 million in the first quarter of 2010 from $21.5 million for the comparable period in 2009. Revenue for the III-V product family increased 110% to $14.5 million from $6.9 million in the same period of 2009, while display revenue was $10.9 million in the first quarter of 2010 compared with $14.6 million in the same period of 2009. Kopin reported net income of $1.0 million, or $0.02 per diluted share, for the 2010 first quarter compared with $1.9 million, or $0.03 per diluted share, for the comparable period in 2009. Kopin ended the first quarter of 2010 with $119.0 million in cash and marketable securities and no debt, an increase of $4.5 million from December 26, 2009. Research and development revenues more than doubled in the first quarter of 2010 to $1.6 million from $0.9 million in the first quarter of 2009, reflecting an increase in design activity associated with military programs and displays for consumer electronics. Kopin®
has received a $16M follow-on
production order of display modules for the U.S. Army‘s Thermal Weapon Sight (TWS) program. This order, to be fulfilled over a 15-month period star- ting this September, supports continued production of Kopin‘s high-performance 640M display module for the Light, Medium, and Heavy Thermal Weapon Sights (LTWS, MTWS, HTWS).
http://www.kopin.com
L
eica Microsystems presents a smart solution for superior contrast in fluorescence imaging. Intel-
ligent Structured Illumination Microscopy uses the proven OptiGrid®
technique. Working in harmony
with Leica’s superior quality optics, the aperture di- aphragm integrated with the fluorescence light path also enhances contrast. The automatic focus function of the OptiGrid®
keeps the grid structure in focus, from UV to IR light.
A unique feature of this development is that the same OptiGrid®
module can be used both for upright
and for inverted Leica research microscopes. Fur- thermore, there is no need to change the grid, as one optimized grid covers all magnifications from 10x to 100x, which offers convenience, avoids errors, and saves valuable time.
http://www.leica-microsystems.com
L
eonardo Biosystems, a portfolio company of Arrowhead Research Corporation (NASDAQ:
ARWR), has received a $2.5 million grant from the Texas Emerging Technology Fund, a state fund established to accelerate commercialization of new technologies. Leonardo Biosystems, co-founded by prominent nanoscientist Dr. Mauro Ferrari, professor at the University of Texas, and Arrowhead’s, CEO Dr. Christopher Anzalone, is engineering a multi-stage drug delivery platform to improve the effectiveness of drug therapy, particularly for cancer.
http://www.arrowheadresearch.com
L
una Innovations Incorporated (NASDAQ: LUNA) announced its financial results for the first quarter
ended March 31, 2010. As compared to the same quarter last year, product and license revenue increased by 29%, from $1.6 million in the first
10-05/06 :: May/June 2010
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83